Dr. Philip F Bongiorno, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 600 Sw College Ave Ste 202, Topeka, KS 66606 Phone: 785-270-5115 Fax: 785-270-7309 |
Bastian Jakub Wilhelm, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 830 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-8625 |
Lori Kaur Soni, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 830 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-8625 |
Dr. Shantikumar K Gandhi, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 830 Sw Mulvane St, Topeka, KS 66606 Phone: 785-233-1710 Fax: 785-233-6342 |
Dr. Ashley Ann Mann, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 600 Sw College Ave, Topeka, KS 66606 Phone: 785-295-8000 |
Dr. David W Lutes, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 830 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-8625 Fax: 785-270-8624 |
Zaynoun El Khoury, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 830 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-8625 |
News Archive
StockPreacher.com announces an investment report featuring Generex Biotechnology Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Northwest Biotherapeutics, a biotechnology company developing DCVax-L personalized immune therapies for solid tumor cancers, today announced that its Phase III clinical trial with DCVax-L for brain cancer has been initiated at King's College Hospital in the UK.
Integrated Diagnostics today announced the e-publication of full results of a large prospective clinical trial validating its Xpresys Lung 2 in the peer-reviewed medical journal CHEST¸ the official journal of the American College of Chest Physicians, titled: Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC trial.
High-deductible health insurance plans coupled with health savings accounts (tax-advantaged funds for covering medical costs), are becoming the plan of choice for Connecticut's small businesses newly offering insurance to employees, Hartford Business reports.
Boehringer Ingelheim and Eli Lilly and Company today announced Phase III study results for linagliptin, demonstrating improved glycaemic control in adults with type 2 diabetes (T2D) whose blood glucose is not adequately maintained.
› Verified 9 days ago